BAY 1841788 clinical trials

Stereotactic body radiotherapy with or without Darolutamide for OligoRecurrent prostate cancer: a randomized phase II trial (DART).

This study looks at a new way to treat prostate cancer that has come back in a few spots. Doctors are testing if adding a drug called Darolutamide to a special type of radiation (SBRT) can help stop the cancer from spreading further, compared to radiation alone.